BOSULIF (fbosutinib) Patient Assistance Program
Don’t let the high cost of brand specialty CML therapy disrupt your treatment. We help eligible patients access Bosulif (bosutinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Bosulif (bosutinib) is FDA-approved for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, and for chronic, accelerated, or blast phase Ph+ CML resistant to or intolerant of prior therapy. It is a second-generation BCR-ABL/SRC family kinase inhibitor.
- Without assistance, brand Bosulif costs commonly run approximately $16,000–$18,500 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Bosulif for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Bosulif in the U.S. as of 2026. Other CML TKIs include generic imatinib (Gleevec), generic dasatinib (Sprycel), nilotinib (Tasigna, generic available), ponatinib (Iclusig), and asciminib (Scemblix). Bosulif's advantage is fewer cardiovascular effects than some other TKIs, but with more GI side effects (especially diarrhea).
What Is Bosulif Prescription Assistance Program?
The Bosulif Prescription Assistance Program is a manufacturer-sponsored initiative that provides Bosulif at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for CML patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, oncology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Bosulif costs roughly $16,000–$18,500/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$18,000 | Save ~$17,930/mo |
| CVS Pharmacy | ~$18,500 | Save ~$18,430/mo |
| Walmart | ~$16,500 | Save ~$16,430/mo |
| Costco | ~$16,200 | Save ~$16,130/mo |
Specialty Pharmacy | ~$17,000 | Save ~$16,930/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Bosulif Prescription Program?
The Patient Assistance Program is free to apply for and provides Bosulif at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Bosulif:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $16,000–$18,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Bosulif assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Bosulif Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Bosulif:
Bosulif (bosutinib) is a once-daily oral second-generation BCR-ABL and SRC family tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML). It is structurally distinct from other CML TKIs and has a unique side-effect profile.
How Bosulif Works:
Chronic Myeloid Leukemia (CML) is driven by the BCR-ABL fusion gene, which causes uncontrolled cell proliferation. Bosutinib works by blocking this activity, along with SRC family kinases, to achieve durable molecular responses. It is structurally distinct from other treatments and remains effective against many mutations that resist other therapies, though it does not work against the T315I mutation. While it is associated with fewer cardiovascular events than some alternatives, it is known for causing frequent gastrointestinal issues.
Form and use:
Bosulif is an oral medication taken once daily and must be consumed with food. The standard dosage is 400 mg for newly diagnosed patients, while 500 mg is used for those who are resistant to or intolerant of other treatments. Diarrhea is a very common side effect, particularly during the first two weeks of therapy, and is typically managed with loperamide or dose adjustments. Consistent daily use and monitoring are key to managing the initial gastrointestinal response.
Generic availability:
As of 2026, there is no generic version of Bosulif available in the United States. Patients may have access to other CML treatments that do have generics, such as imatinib, dasatinib, and nilotinib. Other specialized options like ponatinib and asciminib are also available depending on the patient’s specific needs. The choice of therapy is generally determined by a patient’s medical history, specific genetic mutations, and overall drug tolerability.
Warnings:
Bosulif carries warnings for significant gastrointestinal toxicity, including severe diarrhea, as well as risks for hepatotoxicity and myelosuppression. Patients require regular monitoring of blood counts, liver function, and kidney health to ensure safety during treatment. It may also cause fluid retention, cardiac failure, and embryo-fetal toxicity. There are several major drug interactions to watch for, including with strong CYP3A inhibitors and stomach acid reducers like PPIs, which can interfere with how the drug is absorbed.
FAQ (Frequently Asked Questions)
How Much Does Bosulif Cost Without Insurance?
Bosulif costs approximately $16,000–$18,500 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Bosulif at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Bosulif Different From Other CML TKIs?
All CML TKIs target BCR-ABL but differ in side-effect profiles and resistance coverage. Bosulif has fewer cardiovascular and metabolic effects than nilotinib/ponatinib, but more GI side effects (especially diarrhea). Imatinib (Gleevec, generic) has a long track record and is first-line for many newly diagnosed patients. Dasatinib (generic) is faster-acting but has higher rates of pleural effusions and pulmonary hypertension. Choice depends on patient comorbidities, mutation status, and prior therapy.
Why Does Bosulif Cause So Much Diarrhea?
Diarrhea is the most common Bosulif side effect, especially in the first 1–2 weeks of therapy — affecting up to 70–80% of patients. It is generally manageable with loperamide and other antidiarrheals. Diarrhea often improves significantly after the first few weeks. Dose interruption or reduction may be needed for severe cases. Stay hydrated; tell your oncologist about persistent or severe symptoms.
How Will My Doctor Monitor My Response?
BCR-ABL transcript levels (by RT-PCR) are checked at baseline, every 3 months until you achieve major molecular response (MMR, BCR-ABL ≤0.1% IS), then every 3–6 months thereafter. Complete blood counts, comprehensive metabolic panel (LFTs, kidney function), and amylase/lipase are checked regularly.
Can I Take Bosulif With My Stomach Medications?
Acid-reducing medications reduce bosutinib absorption. Proton pump inhibitors (omeprazole, esomeprazole, etc.) should be avoided or used with separated dosing. H2 blockers should be timed at least 2 hours before or 10 hours after Bosulif. Antacids should be timed at least 2 hours apart. Discuss with your pharmacist.
Are There Drug Interactions I Should Know About?
Yes. Bosutinib is metabolized by CYP3A. Strong CYP3A inhibitors substantially raise levels (avoid). Strong CYP3A inducers substantially lower levels (avoid). PPIs and H2 blockers reduce absorption (timing precautions). Bosutinib also affects metabolism of P-gp substrates. Tell every prescriber and pharmacist about Bosulif.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a different CML TKI with its own PAP (generic imatinib much cheaper; generic dasatinib; or generic nilotinib), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Leukemia & Lymphoma Society, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Bosulif, our team may be able to help you access assistance programs designed to make brand specialty CML therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.